OTTAWA, Jan. 20, 2012 /CNW/ - Rx&D President Russell Williams made the following statement to
complement the joint announcement made by Western Economic
Diversification Canada and Pfizer Canada Inc. of $500,000 each towards
the Alberta Pfizer Collaboration Fund.
"Today's investment is another example of how Government and industry
can come together to drive innovation - translating today's research
into new medicines and therapies tomorrow.
"Collaboration with universities and research hospitals, support for
innovation and help to commercialize new ideas are critical for
Alberta's knowledge-based economy. In 2010, Rx&D members invested $1.3
billion in life science research and development across Canada.
"These public-private partnerships strengthen Canada's position as a
world leader in life sciences. Rx&D members are proud to be one of the
leading investors in the sector and we are committed to continue
investing in innovative health care solutions that help Canadians live
longer, feel better and lead more productive lives.
Rx&D is the association of leading research-based pharmaceutical
companies dedicated to improving the health of Canadians through the
discovery and development of new medicines and vaccines. Our community
represents 15,000 men and women working for 50 member companies and
invests more than $1 billion in research and development each year to
fuel Canada's knowledge-based economy. Guided by our Code of Ethical
Practices, our membership is committed to working in partnership with
governments, healthcare professionals and stakeholders in a highly
SOURCE CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX
For further information: